Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Morgan Stanley

CCVAX Expense Ratio & Fees

Ticker CCVAX · · Holdings as of Jun 30, 2026

Expense ratio
1.2%$120/yr per $10k
5-yr return
+2.1%annualized
1-yr return
−11.3%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
69

Bottom line

What is CCVAX's expense ratio?

CCVAX's expense ratio is 1.2%, or about $120 a year on every $10,000 invested. That is more expensive than 70% of small-cap funds we track (median 0.99%). This share class also charges a front-end sales load of up to 5.25%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Jan 27, 2026

CCVAX fee table

Net expense ratio1.2%
Gross expense ratio1.2%
Management fee0.8%
12b-1 (distribution) fee0.25%
Other expenses0.15%
Max front-end sales load5.25%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Jan 27, 2026

What CCVAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
CCVAX$641$886$1,150$1,903

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.2% expense ratio costs roughly $65,300 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).

Cheapest way to own Calvert Small-Cap Fund

All share classes
TickerClassExpense ratioFront load
CALRXCalvert Small-Cap Fund Class R60.86%0%
CSVIXClass I0.95%0%
CCVAXClass A1.2%5.25%
CSCCXClass C1.95%0%